This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of TAS-120 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02052778
Recruitment Status : Unknown
Verified January 2022 by Taiho Oncology, Inc..
Recruitment status was:  Active, not recruiting
First Posted : February 3, 2014
Last Update Posted : January 10, 2022
Sponsor:
Information provided by (Responsible Party):
Taiho Oncology, Inc.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Actual Primary Completion Date : May 29, 2021
Estimated Study Completion Date : June 30, 2022
Certification/Extension First Submitted : September 28, 2021
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 September 27, 2023
October 24, 2023
2 January 3, 2024
January 29, 2024
3 February 20, 2024